Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Antibodies against food antigens in patients with autistic spectrum disorders.

de Magistris L, Picardi A, Siniscalco D, Riccio MP, Sapone A, Cariello R, Abbadessa S, Medici N, Lammers KM, Schiraldi C, Iardino P, Marotta R, Tolone C, Fasano A, Pascotto A, Bravaccio C.

Biomed Res Int. 2013;2013:729349. doi: 10.1155/2013/729349. Epub 2013 Aug 1.

2.

In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines.

Fiorentino M, Lammers KM, Levine MM, Sztein MB, Fasano A.

Front Immunol. 2013 Feb 12;4:17. doi: 10.3389/fimmu.2013.00017. eCollection 2013.

3.

Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity.

Sapone A, Lammers KM, Casolaro V, Cammarota M, Giuliano MT, De Rosa M, Stefanile R, Mazzarella G, Tolone C, Russo MI, Esposito P, Ferraraccio F, Cartenì M, Riegler G, de Magistris L, Fasano A.

BMC Med. 2011 Mar 9;9:23. doi: 10.1186/1741-7015-9-23.

4.

Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease.

Lammers KM, Khandelwal S, Chaudhry F, Kryszak D, Puppa EL, Casolaro V, Fasano A.

Immunology. 2011 Mar;132(3):432-40. doi: 10.1111/j.1365-2567.2010.03378.x. Epub 2010 Nov 23.

5.

Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease.

Sapone A, Lammers KM, Mazzarella G, Mikhailenko I, Cartenì M, Casolaro V, Fasano A.

Int Arch Allergy Immunol. 2010;152(1):75-80. doi: 10.1159/000260087. Epub 2009 Nov 24.

6.

Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2.

Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S, Arrietta MC, Meddings JB, Fasano A.

Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16799-804. doi: 10.1073/pnas.0906773106. Epub 2009 Sep 15.

7.

Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.

Lammers KM, Lu R, Brownley J, Lu B, Gerard C, Thomas K, Rallabhandi P, Shea-Donohue T, Tamiz A, Alkan S, Netzel-Arnett S, Antalis T, Vogel SN, Fasano A.

Gastroenterology. 2008 Jul;135(1):194-204.e3. doi: 10.1053/j.gastro.2008.03.023. Epub 2008 Mar 21.

8.

The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study.

Paterson BM, Lammers KM, Arrieta MC, Fasano A, Meddings JB.

Aliment Pharmacol Ther. 2007 Sep 1;26(5):757-66.

9.

Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease.

Bresso F, Askling J, Astegiano M, Demarchi B, Sapone N, Rizzetto M, Gionchetti P, Lammers KM, de Leone A, Riegler G, Nimmo ER, Drummond H, Noble C, Torkvist L, Ekbom A, Zucchelli M, Lofberg R, Satsangi J, Pettersson S, D'Amato M.

Inflamm Bowel Dis. 2007 May;13(5):531-6.

PMID:
17206681
10.

Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue.

Massi M, Ioan P, Budriesi R, Chiarini A, Vitali B, Lammers KM, Gionchetti P, Campieri M, Lembo A, Brigidi P.

World J Gastroenterol. 2006 Oct 7;12(37):5987-94.

11.

Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells.

Helwig U, Lammers KM, Rizzello F, Brigidi P, Rohleder V, Caramelli E, Gionchetti P, Schrezenmeir J, Foelsch UR, Schreiber S, Campieri M.

World J Gastroenterol. 2006 Oct 7;12(37):5978-86.

12.

Antibiotics and probiotics in treatment of inflammatory bowel disease.

Gionchetti P, Rizzello F, Lammers KM, Morselli C, Sollazzi L, Davies S, Tambasco R, Calabrese C, Campieri M.

World J Gastroenterol. 2006 Jun 7;12(21):3306-13. Review.

13.

Antimicrobials in the management of inflammatory bowel disease.

Gionchetti P, Rizzello F, Lammers KM, Morselli C, Tambasco R, Campieri M.

Digestion. 2006;73 Suppl 1:77-85. Epub 2006 Feb 8. Review.

PMID:
16498255
14.

Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis.

Lammers KM, Ouburg S, Morré SA, Crusius JB, Gionchett P, Rizzello F, Morselli C, Caramelli E, Conte R, Poggioli G, Campieri M, Peña AS.

World J Gastroenterol. 2005 Dec 14;11(46):7323-9.

15.

VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics.

Gionchetti P, Lammers KM, Rizzello F, Campieri M.

Gastroenterol Clin North Am. 2005 Sep;34(3):499-513, ix-x. Review. No abstract available.

PMID:
16084310
16.

Probiotics and barrier function in colitis.

Gionchetti P, Lammers KM, Rizzello F, Campieri M.

Gut. 2005 Jul;54(7):898-900. Review.

17.

Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression.

Lammers KM, Vergopoulos A, Babel N, Gionchetti P, Rizzello F, Morselli C, Caramelli E, Fiorentino M, d'Errico A, Volk HD, Campieri M.

Inflamm Bowel Dis. 2005 May;11(5):447-54.

PMID:
15867584
18.

Probiotic therapy to prevent pouchitis onset.

Gionchetti P, Rizzello F, Poggioli G, Morselli C, Lammers KM, Campieri M.

Dis Colon Rectum. 2005 Jul;48(7):1493; author reply 1493-4. No abstract available.

PMID:
15793632
19.

Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.

Lammers KM, Brigidi P, Vitali B, Gionchetti P, Rizzello F, Caramelli E, Matteuzzi D, Campieri M.

FEMS Immunol Med Microbiol. 2003 Sep 22;38(2):165-72.

20.

The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial.

Berger RS, Fu JL, Smiles KA, Turner CB, Schnell BM, Werchowski KM, Lammers KM.

Br J Dermatol. 2003 Aug;149(2):354-62.

PMID:
12932243
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk